Facts from the filing
Form 4 · Non-derivative, table I- Disclosed value
- −$1,175,089.07Shares × reported price
- Shares traded
- 4,993ResMed Common Stock
- Price per share
- $235.35Reported price. Read footnotes for ranges.
- % of reported position traded
- 1.03%This security and ownership context
- Holdings after
- 479,803Direct
- Trade date
- Nov 9, 2026Sell
- Filed
- Nov 12, 2026, 6:04 AM ET3-day reporting delay
- Accession
- 0000943819-26-000091Code S · Transaction 398157
How reported position traded is calculated
Shares sold ÷ (holdings after + shares sold). Estimated position before: 484,796 shares.
Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.